menu
    • menu

    Company profile for Evommune

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Evommune is using the skin as the lens to uncover new approaches for accelerating the development of vital medicines across immunology and dermatology. Utilizing a novel screening platform, we identify molecules that are differentiated and that have a greater probability of being effective in treating patients. Our team has a track record of drug approvals and commercial successes. At Evommune, we are building off our extensiv...
    Evommune is using the skin as the lens to uncover new approaches for accelerating the development of vital medicines across immunology and dermatology. Utilizing a novel screening platform, we identify molecules that are differentiated and that have a greater probability of being effective in treating patients. Our team has a track record of drug approvals and commercial successes. At Evommune, we are building off our extensive experience to connect disciplines that address inflammatory disease. Our dedication to science and innovation drives us in our pursuit to identify, discover, and develop unique and vital medicines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EvommuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Los Altos, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.evommune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Evommune Announces $125 Million Private Placement
    Evommune Announces $125 Million Private Placement

    13 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-13/evommune-announces-125-million-private-placement

    PHARMIWEB
    13 Feb 2026
    Share Share
    Evommune's Dupixent-Like Eczema Data Drive 75% Stock Rally
    Evommune's Dupixent-Like Eczema Data Drive 75% Stock Rally

    10 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/evommunes-dupixent-phase-2-eczema-data-drive-75-stock-rally

    FIERCE BIOTECH
    10 Feb 2026
    Share Share
    Evommune Reveals Q3 2025 Financials And Business Update
    Evommune Reveals Q3 2025 Financials And Business Update

    11 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251211387121/en/Evommune-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    11 Dec 2025
    Share Share
    Evommune Closes IPO With Full Underwriters Option Exercise
    Evommune Closes IPO With Full Underwriters Option Exercise

    08 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/evommune-announces-closing-of-its-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-302609041.html

    PR NEWSWIRE
    08 Nov 2025
    Share Share
    Evommune Announces Pricing Of Its Initial Public Offering
    Evommune Announces Pricing Of Its Initial Public Offering

    05 Nov 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/evommune-announces-pricing-of-its-initial-public-offering-302606409.html

    PR NEWSWIRE BIO
    05 Nov 2025
    Share Share
    Evommune To Raise $160M In IPO For Immuno Pipeline
    Evommune To Raise $160M In IPO For Immuno Pipeline

    31 Oct 2025

    // BIOSPACE

    https://www.biospace.com/business/evommune-joins-ipo-class-with-planned-160m-raise-for-immuno-pipeline

    BIOSPACE
    31 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search